Literature DB >> 26596701

ε-Viniferin, a resveratrol dimer, prevents diet-induced obesity in mice.

Kazuaki Ohara1, Kaori Kusano2, Sayoko Kitao2, Takaaki Yanai3, Ryoji Takata3, Osamu Kanauchi2.   

Abstract

Red wines are thought to be one of the major dietary sources of trans-resveratrol. The beneficial effects of t-resveratrol against metabolic disorders have been well characterized, however, red wines also contain various resveratrol derivatives whose health benefits have not been completely elucidated. In this report, we investigated ε-viniferin, a resveratrol dimer, which is present at comparable concentrations to t-resveratrol in red wines, and has higher anti-adipogenesis activity in 3T3-L1 cells. In addition, ε-viniferin was more effective than t-resveratrol in its anti-obesity and anti-inflammatory effects in high-fat diet fed mice. These results suggested ε-viniferin may be one of the active ingredients against metabolic disorders in red wines, in addition to t-resveratrol.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Grape shoot extract; Obesity; Resveratrol; ε-Viniferin

Mesh:

Substances:

Year:  2015        PMID: 26596701     DOI: 10.1016/j.bbrc.2015.11.047

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  Anti-obesity effects of resveratrol: comparison between animal models and humans.

Authors:  Alfredo Fernández-Quintela; Christian Carpéné; Maialen Fernández; Leixuri Aguirre; Iñaki Milton-Laskibar; José Contreras; Maria P Portillo
Journal:  J Physiol Biochem       Date:  2016-12-15       Impact factor: 4.158

Review 2.  In the shadow of resveratrol: biological activities of epsilon-viniferin.

Authors:  Pauline Beaumont; Arnaud Courtois; Claude Atgié; Tristan Richard; Stéphanie Krisa
Journal:  J Physiol Biochem       Date:  2022-03-21       Impact factor: 4.158

3.  Anti-inflammatory effect of oligostilbenoids from Vitis heyneana in LPS-stimulated RAW 264.7 macrophages via suppressing the NF-κB activation.

Authors:  Do Thi Ha; Phung Thanh Long; Tran Thi Hien; Dao Trong Tuan; Nguyen Thi Thuy An; Nguyen Minh Khoi; Ha Van Oanh; Tran Manh Hung
Journal:  Chem Cent J       Date:  2018-02-13       Impact factor: 4.215

4.  Tissular Distribution and Metabolism of trans-ε-Viniferin after Intraperitoneal Injection in Rat.

Authors:  Arnaud Courtois; Claude Atgié; Axel Marchal; Ruth Hornedo-Ortega; Caroline Lapèze; Chrystel Faure; Tristan Richard; Stéphanie Krisa
Journal:  Nutrients       Date:  2018-11-04       Impact factor: 5.717

5.  Encapsulation of ε-Viniferin into Multi-Lamellar Liposomes: Development of a Rapid, Easy and Cost-Efficient Separation Method to Determine the Encapsulation Efficiency.

Authors:  Pauline Beaumont; Arnaud Courtois; Tristan Richard; Stéphanie Krisa; Chrystel Faure
Journal:  Pharmaceutics       Date:  2021-04-16       Impact factor: 6.321

6.  Novel natural and synthetic inhibitors of solute carriers SGLT1 and SGLT2.

Authors:  Paul Oranje; Robin Gouka; Lindsey Burggraaff; Mario Vermeer; Clément Chalet; Guus Duchateau; Pieter van der Pijl; Marian Geldof; Niels de Roo; Fenja Clauwaert; Toon Vanpaeschen; Johan Nicolaï; Tom de Bruyn; Pieter Annaert; Adriaan P IJzerman; Gerard J P van Westen
Journal:  Pharmacol Res Perspect       Date:  2019-07-30

7.  Trans-ε-Viniferin Encapsulation in Multi-Lamellar Liposomes: Consequences on Pharmacokinetic Parameters, Biodistribution and Glucuronide Formation in Rats.

Authors:  Pauline Beaumont; Chrystel Faure; Arnaud Courtois; Michael Jourdes; Axel Marchal; Pierre-Louis Teissedre; Tristan Richard; Claude Atgié; Stéphanie Krisa
Journal:  Nutrients       Date:  2021-11-24       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.